Stay updated on NSCLC Combination Therapy Clinical Trial
Sign up to get notified when there's something new on the NSCLC Combination Therapy Clinical Trial page.
Latest updates to the NSCLC Combination Therapy Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page now displays the phase 3 metastatic NSCLC study record, including its design, eligibility criteria, locations, and outcome measures, instead of a 403 access-denied screen.SummaryDifference100%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov revision as v3.8.0 instead of v3.7.2. The study record remains inaccessible and displays a 403 Forbidden error.SummaryDifference0.2%
- Check23 days agoChange DetectedA banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%
- Check29 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.2 instead of v3.7.1.SummaryDifference0.2%
- Check36 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error, with an updated site revision number in the footer.SummaryDifference0.2%
- Check51 days agoChange DetectedAccess to the study record now displays a 403 Forbidden error instead of the expected content; the HTML shows a 403 header and a Home link indicating restricted access to the record.SummaryDifference19%
Stay in the know with updates to NSCLC Combination Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Combination Therapy Clinical Trial page.